Context Therapeutics Inc. (CNTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$2.46
+5.13%
Mkt Cap $215.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | -$1.46M | — | — | -$0.11 | -$0.14 | -27.27% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.09 | -$0.10 | -11.11% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$0.06 | -$0.09 | -50.00% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$0.05 | -$0.05 | +0.00% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.05 | -$0.04 | +20.00% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.11 | -$0.22 | -100.00% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.08 | -$0.04 | +50.00% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.38 | -$0.23 | +39.47% | — | — |
| Q1 2024 Mar 21, 2024 | — | $18.95K | — | -$0.35 | -$0.42 | -20.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.30 | -$0.37 | -23.33% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.20 | -$0.31 | -55.00% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.19 | -$0.40 | -110.53% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$0.30 | -$0.22 | +26.67% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.25 | -$0.24 | +4.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.24 | -$0.22 | +8.33% | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$0.27 | -$0.30 | -12.16% | — | — |
| Q4 2021 Dec 2, 2021 | — | — | — | — | -$4.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.73 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.09 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.08 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.09 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | $21.47 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | $0.08 | — | — | — |